Related references
Note: Only part of the references are listed.Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial
TN Brooklyn et al.
GUT (2006)
Pyoderma gangrenosum: uncommon presentations
S Ahmadi et al.
CLINICS IN DERMATOLOGY (2005)
Severe recalcitrant pyoderma gangrenosum treated with infliximab
MR Kaur et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Successful treatment of therapy-resistant chronic vegetating pyoderma gangrenosum with infliximab (chimeric antitumour necrosis factor antibody)
L Jenne et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Generation and regulation of human Th1-biased immune responses in vivo: A critical role for IL-4 and IL-10
A Skapenko et al.
JOURNAL OF IMMUNOLOGY (2004)
Cutaneous vasculitis: a review
AN Crowson et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2003)
Share Paper
